Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03081143
Title Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy (RAMIRIS)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Paclitaxel + Ramucirumab

Fluorouracil + Irinotecan + Leucovorin + Ramucirumab

Age Groups: adult | senior
Covered Countries DEU | AUT


No variant requirements are available.